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Is depression associated with dysfunction of the central reward
system?
Abstract
The neural substrates of MDD (major depressive disorder) are complex and not yet fully understood. In
the present review, I provide a short overview of the findings supporting the hypothesis of a
dysfunctional dopamine system in the pathophysiology of depression. Because the mesocorticolimbic
dopamine system is involved in reward processing, it has been hypothesized that a reduced function of
this system could underlie the anhedonia and amotivation associated with depression. This hypothesis is
supported by several observations providing indirect evidence for reduced central dopaminergic
transmission in depression. However, some of the differences observed between controls and depressed
patients in dopamine function seem to be specific to a subsample of patients, and influenced by the
methods chosen. Studies that investigated the neural bases of some MDD behavioural symptoms
showed that anhedonia, loss of motivation and the diminished ability to concentrate or make decisions
could be associated with a blunted reaction to positive reinforcers and rewards on one side, and with a
bias towards negative feedback on the other side. Only a few studies have investigated the neural basis
of anhedonia and the responses to rewards in MDD subjects, mostly evidencing a blunted response to
reward signals that was associated with reduced brain activation in regions associated with the brain
reward system. In conclusion, there is evidence for a dysfunction of the dopamine system in depression
and for blunted response to reward signals. However, the exact nature of this dysfunction is not yet clear
and needs to be investigated in further studies.
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Abstract
The neural substrates of major depressive disorder (MDD) are complex and not fully understood 
yet. In this review, we provided a short overview of the findings supporting the hypothesis of a 
dysfunctional dopamine system in the pathophysiology of depression. Because the mesocorticolimbic 
DA system is involved in reward processing, it has been hypothesized that a reduced function of this 
system could underlie the anhedonia and amotivation associated with depression. This hypothesis is 
supported by several observations providing indirect evidence for reduced central dopaminergic 
transmission in depression. However, some of the differences observed between controls and 
depressed patients in DA function seem to be specific to a subsample of patients, and influenced by 
the methods chosen. Studies that investigated the neural bases of some MDD behavioural symptoms 
showed that anhedonia, loss of motivation and the diminished ability to concentrate or make decisions 
could be associated with a blunted reaction to positive reinforcers and rewards on one side, and with a 
bias towards negative feedback on the other side. Only few studies have investigated the neural basis 
of anhedonia and the responses to rewards in MDD subjects, mostly evidencing a blunted response to 
reward signals that was associated with reduced brain activation in regions associated with the brain 
reward system. In conclusion, there is evidence for a dysfunction of the DA system in depression and 
for blunted response to reward signals. However, the exact nature of this dysfunction is not clear yet 
and need to be investigated in further studies.
1. Introduction
Major depressive disorder (MDD) ranked among the top 10 causes of worldwide disability in 
1996 and is expected to rise to the second cause of disability in the world by 2020 [1]. According to 
the Diagnostic Statistical Manual (DSM)-IV [2], MDD is characterized by the presence of at least 5 of 
the following symptoms during the same 2-week period: 1) depressed mood most of the day, nearly 
every day; 2) diminished interest or pleasure in all, or almost all, activities (anhedonia); 3) significant 
weight gain or weight loss or a decrease or increase of appetite; 4) insomnia or hypersomnia nearly 
every day; 5) psychomotor agitation or retardation; 6) fatigue or loss of energy; 7) feelings of 
worthelessness or excessive or inappropriate guilt; 8) diminished ability to think or concentrate; 9) 
recurrent thoughts of death and /or suicidal ideation. 
The neural substrates of MDD are complex and not fully understood yet. For instance, the 
results obtained with neuroimaging studies in depressed patients are in part contradictory and suggest 
that the pathophysiology of MDD involves several neuroanatomical substrates and neurotransmitter 
systems [3]. Willner [4] postulated that a functional impairment of the mesolimbic dopamine (DA) 
pathway underlies the core MDD symptoms of anhedonia and loss of motivation. This hypothesis is 
consistent with findings showing that euphoria correlated with amphetamine-induced DA release in 
the human ventral striatum [5] and that cerebral blood flow differences between depressed patients and 
controls were identified in regions associated with the mesolimbic DA system, including amygdala, 
striatum, anterior cingulate gyrus and prefrontal cortex [3, 6]. The mesolimbic DA pathway is also 
involved in the processing of reward information in the brain (see[7, 8] for review). Reward is in turn 
an important determinant of motivated behaviour, and obtaining reward is associated with pleasant 
feelings.
Here we will provide a short review of the findings supporting the hypothesis of a dysfunctional 
dopamine system in the pathophysiology of depression. We will first explain the relationship between 
the mesolimbic dopamine (DA) system and the cerebral reward system. Then, we will give an 
overview of the results suggesting that these systems could be dysfunctional in depressed patients.
2. Reward and the dopamine system 
The search for the neural substrates of reward began with the discovery of intracranial self-
stimulation (ICSS) by Olds and Milner [9], who observed that rats with electrodes implanted in certain 
brain sites, such as the lateral hypothalamus, would press a lever to discharge electrical stimulation 
through the electrodes. Crow & Deakin [10] showed that ICSS could be obtained in a range of sites 
extending through the lateral hypothalamus into the ventral tegmentum of the midbrain. 
Major advances in the understanding of ICSS results were made with the discovery of a 
chemical specificity for ICSS. Pharmacological investigations showed that ICSS was influenced by 
psychotropic drugs, which act on catecholamine neurons, including chlorpromazine, an antipsychotic 
drug, reserpine, an antidepressive drug [11], as well as amphetamine [12] and cocaine [13], both 
acting on DA transmission. These findings led to the hypothesis that the ascending catecholamine 
systems constituted a catecholamine reward pathway. Much data pointed to contribution of 
mesolimbic and mesocortical dopamine systems in brain reward mechanisms [10].
This hypothesis was supported by neurophysiological studies in awake primates, which showed 
that neurons located in regions associated with the DA system, including the striatum, the amygdala 
and the orbitofrontal cortex (OFC) as well as DA midbrain neurons, were activated by food and liquid 
rewards (see [14] for review). More specifically, DA neurons have been shown to be involved in 
reward-related learning. Therefore, in procedures involving Pavlovian conditioning, DA neurons that 
responded initially to a food or liquid reward, the unconditioned stimulus (US), acquire a response to 
the cues associated with the delivery of reward, the conditioned stimuli (CS), after repeated pairings 
[15]. Such neuronal responses are strongly diminished after extinction [16, 17], and are modulated by 
dopamine [18]. Additionally, DA neurons and some OFC neurons exhibit firing related to the coding 
of prediction errors, i.e., higher firing rate to unpredicted than to predicted rewards, and no response 
when rewards are omitted [19]. 
Finally, human studies using neuroimaging methods also provided evidence for an implication 
of the mesolimbic and mesocortical DA systems in the processing of reward. Thus, the ventral 
striatum was shown to be activated in response to a broad range of reinforcers [20-22] as well as 
during the expectation of monetary reward [23]. Activation in response to reward and behavioral 
reinforcement was also found in other brain regions associated with the mesolimbic DA system, 
including the anterior cingulate gyrus (ACC) and OFC [24-27]. In addition, the dorsal striatum, 
including putamen and caudate nucleus, and the ventral striatum, mostly the nucleus accumbens 
(Nacc) as well as the OFC were activated in procedures testing reward-related learning [28-30]. From 
those regions, the ventral putamen and the OFC were shown to be activated during appetitive 
Pavlovian conditioning in a way that was compatible with the predictions obtained with the temporal 
difference model [31-33]. At last, some studies investigated the direct implication of DA in response 
to rewards using the [11C] raclopride positron emission tomography (PET) method. [11C] Raclopride 
is a radioligand that is sensitive to changes in intrasynaptic DA concentrations and a decrease of [11C] 
raclopride binding is thought to reflect endogeneous DA release [34]. Using this method, [35] showed 
that [11C]-raclopride binding decreased in the ventral striatum in response to large monetary rewards 
versus large monetary losses, and [36] found that [11C]raclopride binding decreased in the putamen 
and caudate in response to unpredictable versus predictable rewards. However, further studies [37] 
suggested that active behavioural engagement was essential to induce a change in striatal raclopride 
binding in response to unpredictable rewards.
Taken together, these results point to an involvement of the mesocorticolimbic, and mesostriatal 
DA systems in the processing of reward information. Brain regions associated with these 
neurotransmitter systems are activated in response to rewarding stimuli, suggesting that the cerebral 
reward circuitry comprised at least the following regions: ventral and dorsal striatum, OFC and ACC. 
An implication of the amygdala was also evidenced in some human neuroimaging studies and in the 
formation of stimulus-reward associations in animals [26, 38]. However, the function of DA in the 
processing of reward remains unclear. Even if many studies suggest that DA mediates some aspects of 
reward-related learning (see above), there is some evidence that DA could transmit the hedonic value 
of rewarding stimuli. For instance, Wise demonstrated that dopamine blockade impaired primary 
reinforcement [39]. More recently, the findings from PET-studies of amphetamine- or 
methylphenidate-induced DA release showing that the euphoria associated with these agents 
correlated with DA release in the anteroventral striatum and the ventral putamen [5, 40, 41], yielded 
new support for the hypothesis that DA could be involved in the mediation of the hedonic feelings 
related to rewards.
3. Dopamine function in MDD
The role of the mesocorticolimbic DA system in reward processing and in the mediation of the 
hedonic value of stimuli, led to the hypothesis that a reduced function of this system could underlie the 
anhedonia, amotivation, and psychomotor slowing associated with depression [4, 42, 43]. This 
hypothesis is supported by several observations providing indirect evidence for reduced central 
dopaminergic transmission in depression (as reviewed in [44]. First, in depressed patients, 
concentrations of the DA metabolite, homovanillic acid, are consistently reduced in the cerebrospinal 
fluid (CSF) and jugular vein plasma in vivo [45-47]. Secondly, DA receptor agonists (eg pramipexole) 
exert antidepressant effects in placebo-controlled studies [48, 49]. Thirdly, catecholamine depletion 
induces depression in susceptible individuals [50, 51]. Finally, neuroreceptor imaging studies of MDD 
showed a reduced [11C]L-DOPA uptake across the blood-brain barrier [52] and loss of the normal 
asymmetry in striatal D(1) receptor binding [53]. Increased striatal binding to D2/D3 receptors was 
evidenced in depressives with psychomotor slowing [54], but studies whose samples were not 
predominantly composed of psychomotor slowed cases found no difference in D2/D3 receptor levels 
during depression [55-58]. Similarly, a reduced striatal DA transporter (DAT) binding in MDD 
compared to controls was found in some [59, 60], but not in all studies of striatal DAT of MDD [61-
63].
In summary, most of the findings reviewed point to a dysfunction of the central DA function 
in MDD. However, the exact nature of this dysfunction is difficult to understand since some of the 
differences observed between controls and depressed patients in DA function seem to be specific to a 
subsample of patients and influenced by the methods chosen. These differences among the studies 
make any attempt at generalization difficult. One way to get out of this dilemma is to investigate DA 
function during behavioural activation that is associated with MDD symptoms. In the next section, we 
will provide an overview on the studies that tried to elucidate the brain mechanisms of MDD 
behavioural symptoms, mainly those of anhedonia and loss of motivation.  
4. P  rocessing of reward information in MDD  
Some MDD behavioural symptoms including anhedonia, loss of motivation, and the 
diminished ability to concentrate or make decisions, could be associated with a blunted reaction to 
positive reinforcers and rewards on one side, and with a bias towards negative feedback on the other 
side. The hypothesis that depressed patients manifest an abnormal response to negative feedback, is 
consistent with the findings that depressed patients respond catastrophically to error feedback on 
memory or planning tasks, in that they are disproportionately likely to commit an error on a trial that 
follows negative feedback [64, 65]. Abnormal response to negative feedback was also reported on a 
probabilistic reversal learning task where subjects were requested to ignore misleading negative 
feedback to correct responses on 20% of trials. MDD patients reversed in response to the misleading 
task feedback, while showing intact rule acquisition, and normal levels of response perseveration 
when the rule actually reversed [66]. These cognitive effects are specific to depression [64], and were 
also evidenced in remitted depressed patients [67], suggesting that abnormal reactions to negative 
feedback may extend to samples with increased risk for depression, even in the absence of current 
symptoms. A functional Magnetic Resonance Imaging (fMRI)-study investigating the neural 
correlates of the sensitivity to negative feedback in MDD [68] suggested that a disrupted control by 
the prefrontal cortex of the amygdala may underlie these abnormal responses to negative feedback.
Testing the hypothesis that MDD patients show a blunted reaction to positive reinforcers [69] 
evidenced that currently depressed subjects, but not remitted depressed subjects, express a diminished 
responsiveness  to  anticipated  reward.  A  fMRI-study  [70]  investigating  the  neural  responses  to 
monetary  incentives  in  MDD  showed  that  depressed  individuals  did  not  differ  from  control 
participants in their behavioural responses, and recruited the Nacc during gain anticipation. However, 
MDD subjects showed an increased activity of the ACC in response to increasing gains, a region that 
was activated in response to increasing losses in the controls. Together with the fact that MDD showed 
a  reduced  discrimination  of  gain  versus  nongain  outcomes,  these  results  support  the  idea  of  an 
increased conflict during anticipation of gains. Based on the temporal difference model of DA (see 
section 2),  a further fMRI-study [71] showed that  long-term medicated MDD patients exhibited a 
reduced reaction to reward-learning signals among others in the ventral striatum and ACC.  Finally, 
preliminary  results  from  an  fMRI-study  of  appetitive  conditioning  show  dysfunctional 
learning  in  both  appetitive  and  aversive  learning  conditions  associated  with  a  pattern  of 
dysfunction of amygdala, lateral OFC, striatum (caudate nucleus) and ACC in unmedicated 
MDD patients [72]. 
Using a dopaminergic probe consisting of the oral administration of dextroamphetamine 
sulphate, [73] showed that severity of depression correlated highly with the rewarding effects of 
dextroamphetamine in a group of unmedicated depressed patients, and that MDD subjects with severe 
symptoms reported significantly greater rewarding effects than controls. These results evidence a 
hypersensitive response of the brain reward system that could be related to a DA hypofunction. In a 
further study [74], these authors demonstrated that this hypersensitive response to the rewarding 
effects of dextroamphetamine in MDD was associated with a reduction of the brain activation in the 
ventromedial prefrontal cortex, the OFC, and the ventral striatum. 
In summary, only few studies have investigated the neural basis of anhedonia, and the 
responses to rewards in MDD subjects, mostly evidencing a blunted response to reward signals that 
was associated with reduced brain activation in regions associated with the brain reward system.
5. Conclusion and future directions
We provided here a brief overview of the findings suggesting that a dysfunction of the 
cerebral reward system could contribute to the pathophysiology of major depressive disorder. The role 
of the mesocorticolimbic DA system in reward processing and in the mediation of the hedonic value of 
stimuli, led to the hypothesis that a reduced function of this system could underlie the anhedonia, 
amotivation, and psychomotor slowing associated with depression. This hypothesis is supported by 
several observations providing indirect evidence for reduced central dopaminergic transmission in 
depression. However, the exact nature of this dysfunction is difficult to understand since some of the 
differences observed between controls and depressed patients in DA function seem to be specific to a 
subsample of patients and influenced by the methods chosen. These differences among the studies 
make any attempt for generalization difficult. One way to get out of this dilemma is to investigate DA 
function during behavioural activation that is associated with MDD symptoms. However, only few 
studies have investigated the neural basis of anhedonia and the neural responses to reward in MDD 
subjects, mostly evidencing a blunted response to reward signals that was associated with a reduced 
brain activation in regions associated with the brain reward system. However, the exact nature of these 
impairments is still unclear.
In conclusion, there is some evidence that a dysfunction of the mesolimbic DA system could 
contribute to the pathophysiology of MDD and could underlie the anhedonia symptoms associated 
with depression. However, only few studies investigated the neural correlates of anhedonia in 
depressed patients and there is a need for more investigations in this field of research.
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